United States eye drops market is
expected to grow at a significant rate during the forecast period. Increasing prevalence of ocular disorders such as
glaucoma, diabetic retinopathy has contributed to increase the demand for
post-operative ocular anti-defective therapies. Emergence of various pathogens
affecting the eyes adversely by increasing the risk of eye infection is
expected to fuel the sales of eye drops in United States. Also, rising cases of
viral conjunctivitis and bacterial infections is surging the demand for eye
drops market.
Increasing in cases of eye surgeries performed in United States
due to presence of superior technology and healthcare infrastructure is fueling
the need for dilation eye drops required to perform eye surgery. Strong
economic presence of United States and increasing GDP is enabling the leading
authorities to invest huge amounts to upgrade the existing healthcare
infrastructure. Favorable reimbursement policies offered by government
authorities to expand the reach of healthcare facilities all over the United
States and make healthcare sector affordable for everyone is expected to
accelerate the market of eye drops. Increasing focus on drug discovery and
development of eye drops for treating the eye disorders coupled with high
awareness regarding maintaining eye health is expected to boost the eye drops
market.
United
States eye drops market is segmented into
type, drug class, disease indication, distribution channel, end user, regional
distribution, and company. Based
on disease indication, market is further divided into dry eye diseases,
glaucoma, eye allergy, eye infections, retinal disorders, and others. The
retinal disorders segment is expected to account for fastest incremental growth
for the forecast period, 2023-2027. Presence of large old age population who
are more prone to retinal disorders require the eye drops thereby fostering the
market growth.
The major players operating in the United
States eye drops market are Bausch Health Companies,
Inc., Alcon, Inc., Johnson & Johnson, Pfizer, Inc., Novartis
Pharmaceuticals Corporation, Allergan, Inc. (AbbVie), Bayer Corporation, Genentech,
Inc. (Roche), Akorn, Inc., KC Pharmaceuticals, Inc., among others. Major
companies are developing advanced technologies and launching new services to
stay competitive in the market. Other competitive strategies include mergers
& acquisitions and new service developments.
Objective of the Study:
- To analyze the historical growth of the market size of United
States eye drops market from 2017 to 2020.
- To estimate and forecast the market size of United States eye drops
market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States eye drops market based on type,
drug class, disease indication, distribution channel, end user, regional
distribution, and company.
- To identify dominant region or segment in the United States eye
drops.
- To identify drivers and challenges for United States eye drops
market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in United States eye drops
market.
- To identify and analyze the profile of leading players operating in
United States eye drops market.
- To identify key sustainable strategies adopted by market players in
United States eye drops market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers who could not be identified
due to the limitations of secondary research. TechSci Research analyzed the manufacturers,
distribution channels and presence of all major players across the globe.
TechSci
Research calculated the market size of United States eye drops market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Eye Drops manufacturing companies
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums, and alliances related
to eye drops market.
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
|
Attribute
|
Details
|
|
Base
Year
|
2021
|
|
Historical
Years
|
2017 –
2020
|
|
Estimated
Year
|
2022E
|
|
Forecast
Period
|
2023F –
2027F
|
|
Quantitative
Units
|
Revenue in
USD Million and CAGR for 2017-2021 and 2022E-2027F
|
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments
Covered | - Type
- Drug Class
- Disease Indication
- Distribution Channel
- End User
|
|
Region
Scope
|
South-Region,
West-Region, Mid-West Region & Northeast-Region
|
|
Key
Companies Profiled
|
Bausch
Health Companies, Inc., Alcon, Inc., Johnson & Johnson, Pfizer, Inc.,
Novartis Pharmaceuticals Corporation, Allergan, Inc. (AbbVie), Bayer
Corporation, Genentech, Inc. (Roche), Akorn, Inc., KC Pharmaceuticals, Inc
|
|
Customization
Scope
|
10% free
report customization with purchase. Addition or alteration to regional &
segment scope.
|
|
Pricing
and Purchase Options
|
Avail
customized purchase options to meet your exact research needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, United States eye drops market
has been segmented into following categories, in addition to the industry
trends which have also been detailed below:
·
United States Eye Drops Market, By Type:
- Prescription
- Over-The-Counter
- United States Eye Drops Market, By Drug Class:
- Antiallergy
- Anti-inflammatory
- Antiglaucoma
- Anti-VEGF
- Others
- United States Eye Drops Market, By Disease Indication:
- Dry Eye
Diseases
- Glaucoma
- Eye
Allergy
- Eye
Infections
- Retinal
Disorders
- Others
- United States Eye Drops Market, By Distribution Channel:
- Hospitals
Pharmacy
- Retail
Pharmacy
- Online Pharmacy
- United States Eye Drops Market, By End User:
- Hospitals
& Clinics
- Homecare
- Others
- United States Eye Drops Market, By Region:
- South
- West
- Mid-West
- North East
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in United States eye drops market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
United States eye drops
market is an upcoming report to be released soon. If you wish an early delivery
of this report or want to confirm the date of release, please contact us at [email protected]